Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+16.05%
-12.55%
-15.72%
-2.98%
MBX
MBX Biosciences Inc.
$14.91
Login to see MBX Biosciences Inc. (MBX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Chart
$9.74 (+53.08%)
$14.31 (+4.19%)
$14.31 (+4.19%)
$14.31 (+4.19%)
MBX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
High volatilty
MBX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
MBX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MBX Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is MBX current stock price?
What are MBX stock strengths?
What risks are associated with MBX stock?
When is MBX next earnings report?
What is MBX market cap and volume?
What is MBX's current Stock IQ?
Should I buy MBX stock right now?
Is MBX a Strong Buy right now?
What does a 'Strong Buy' rating mean for MBX?
What does a 'Strong Sell' rating mean for MBX?
What factors influence MBX's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+16.05%
-12.55%
-15.72%
-2.98%
MBX
MBX Biosciences Inc.
Current Price
$14.91
Login to unlock MBX Biosciences Inc. (MBX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$9.74 (+53.08%)
$14.31 (+4.19%)
$14.31 (+4.19%)
$14.31 (+4.19%)
MBX Analysts Opinion
MBX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
MBX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MBX Street view is extremely bullish and have positive views on the near-term outlook
MBX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
High volatilty
Average key support and resistance price levels.
Login to displayMBX Latest Analysis
Wall Street Analysts See a 280.14% Upside in MBX Biosciences Inc. (MBX): Can the Stock Really Move This High?. The average of price targets set by Wall Street analysts indicates a potential upside of 280.1% in MBX Biosciences Inc. (MBX). While the effectiveness of this highly sought-after metric is questionable the positive trend in earnings estimate revisions might translate into an upside in the stock.
Thu Oct 9, 2025
MBX Biosciences Inc. (MBX) Discusses On Topline Results From Avail Phase 2 Trial Transcript.
Wed Sep 24, 2025
Wall Street Analysts Think MBX Biosciences Inc. (MBX) Could Surge 88.55%: Read This Before Placing a Bet. The mean of analysts price targets for MBX Biosciences Inc. (MBX) points to an 88.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Tue Sep 23, 2025
MBX Biosciences To Report Phase 2 Data For Potential Once-Weekly Hypoparathyroidism Drug . (RTTNews) - MBX Biosciences Inc. (MBX) a clinical-stage biopharmaceutical company is scheduled to report topline results from its Avail trial today.
Mon Sep 22, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings
Leaders